Latest Market News

Resolution Minerals secures a $2 million placement from Tribeca Investment Partners, reinforcing its position in the U.S. critical minerals sector and advancing exploration at the strategically important Horse Heaven Project.

Magmatic Resources has successfully raised A$3 million through a discounted placement, with major shareholder FMG Resources increasing its stake to nearly 20%. The funds will accelerate exploration at key copper and gold projects.

Deep Yellow Ltd announces the departure of long-serving CEO John Borshoff, with CFO Craig Barnes stepping in as interim leader while a global search for a successor continues.

Red Sky Energy has mobilised drilling equipment to the KN2 well site at Killanoola, with regulatory approvals advancing smoothly and drilling expected to begin soon.

Wide Open Agriculture has developed a novel lupin protein milk formulation that overcomes longstanding technological hurdles, lodging a patent to protect its innovation and gearing up for global commercialisation.

Perpetual Limited reported a robust first quarter for FY26, with growth across its Asset Management, Corporate Trust, and Wealth Management divisions, driven by strong market returns and strategic initiatives.

Actinogen Medical has fast-tracked recruitment in its XanaMIA Alzheimer’s trial, closing pTau biomarker screening early and increasing participant numbers, aiming for final results by mid Q4 2026.

Beach Energy reported an 8% increase in production to 5.0 million barrels of oil equivalent in Q1 FY26, driven by strong performance in the Otway Basin and Cooper Basin flood recovery. Sales revenue rose 18% to $537 million, supported by two LNG cargoes from the Waitsia Gas Plant, which is now approaching its Ready For Start Up milestone.

Algorae Pharmaceuticals has signed a binding term sheet with India’s Cadila Pharmaceuticals to introduce two generic medicines targeting cardiovascular and metabolic disorders in Australia and New Zealand.

Imricor Medical Systems has completed the world’s first Pulsed Field Ablation procedure under real-time MRI guidance, marking a breakthrough in cardiac ablation technology. This pre-clinical success validates their Vision-MR platform’s adaptability and sets the stage for safer, radiation-free heart treatments.

Orthocell has boosted its investment in Marine Biomedical to secure exclusive global distribution rights for PearlBone™, an innovative bone substitute nearing FDA approval, enhancing its regenerative medicine portfolio.

BrainChip Holdings Ltd showcased its leadership in ultra-low-power edge AI technology, emphasizing strong partnerships and a growing product portfolio targeting high-growth sectors like defense and healthcare.